Previous 10 | Next 10 |
Merger activity increased last week with four new deals announced and five pending deals closing. Deal Statistics New Deals The acquisition of TIER REIT (TIER) by Cousins Properties Incorporated (CUZ) for $2.38 billion in an all stock deal. Under the terms of the agreement, Cous...
ShockWave Medical (NASDAQ: SWAV ) initiated with Equal Weight rating at Morgan Stanley. Initiated with Market Perform rating at Wells Fargo. Initiated with Buy rating with a $39 (17% upside) price target at Canaccord Genuity. Initiated with Neutral rating at BofA/Merrill Lynch. More news o...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify (click the highlighted links). Better growth numbers from China are lifting investing sentiment across the globe as government stim...
Very good news for the merger Bristol-Myers Squibb, or "BMS" ( BMY ) has agreed to acquire Celgene ( CELG ). Each share of CELG will be paid with $50 cash, one share of BMS stock and a contingent value right, or CVR, with a $9 cash payment if three CELG drugs are approved timely. My initia...
On March 29, ISS indicated it is advising in favor of the Celgene ( CELG ) Bristol-Myers ( BMY ) tie-up. The merger is being opposed by activist Starboard Value on the Bristol-Myers side, and it is more or less conceding . We've first written on Celgene on January 9 and followed it up with ...
Prologue Since we mentioned it for the first time four months ago , the US yield curve has inverted further, raising fresh concerns about the risk of an upcoming recession . There are arguments to be made that "this time is different” in interpreting inversion. However, there is...
The FDA approves Merck KGaA ( OTCPK:MKGAY ) unit EMD Serono's Mavenclad (cladribine) tablets for the treatment of relapsing forms of multiple sclerosis (MS). More news on: Merck KGaA ADR, Celgene Corporation, Roche Holding AG, Healthcare stocks news, Read more ...
Alvogen licensed to sell volume-limited amounts of generic lenalidomide in the U.S. beginning on a confidential date after the March 2022 date Celgene previously granted to Natco Alvogen also licensed to sell generic lenalidomide in the U.S. without volume limitation beginning on Janua...
The European Medicines Agency's advisory group CHMP has adopted a positive opinion backing an expanded label for Celgene's (NASDAQ: CELG ) Imnovid (pomalidomide). More news on: Celgene Corporation, Healthcare stocks news, Read more ...
The CHMP adopted two positive opinions recommending European Commission approval of: REVLIMID in combination with bortezomib and dexamethasone (RVd) in adult patients with previously untreated multiple myeloma who are not eligible for transplant IMNOVID in combination with bort...
News, Short Squeeze, Breakout and More Instantly...
Celgene Corporation Company Name:
CELG Stock Symbol:
NASDAQ Market:
In this clip from "The Pharma & Biotech Show" on Motley Fool Live , recorded on Feb. 2 , Motley Fool contributor Brian Orelli analyzes Gilead 's (NASDAQ: GILD) earnings report and discusses why the biotech giant could see fairly low revenue growth or even see earnings dr...
What coronavirus? Amgen 's (NASDAQ: AMGN) latest set of quarterly figures, delivered Tuesday, showed growth in the company's fundamentals during a challenging time for companies across all economic sectors. The veteran biotech company booked revenue of nearly $6.21 billion in the second qu...
It's scary out there right now for investors, with wild market swings and a lot of negative news coming out of quarterly reports. There is one sector, however, that will survive and likely thrive despite the coronavirus pandemic shutdown -- healthcare. That said, investors shouldn't head for jus...